Half Year 2026 Brenntag SE Earnings Call Transcript
Key Points
- Brenntag SE (BNTGF) reported strong volume growth in Specialty, particularly in Material Science, driven by market conditions and successful sales efforts.
- The company achieved a 0.6 percentage point improvement in gross profit margin and a 3.3 percentage point increase in EBITDA conversion in the Specialty segment, indicating enhanced operational efficiency.
- Management highlighted successful commercial execution, including winning back over 1,000 dormant customers in the US, demonstrating effective sales strategies.
- The cost efficiency program is on track, with a run rate of EUR41 million in Q2 and a target of EUR150 million for the year, expected to deliver structural savings.
- Working capital management remains efficient, with working capital turns improving to 7.5 times, and the company expects a temporary peak in working capital to unwind in Q3.
- The company raised its guidance, reflecting confidence in continued positive performance despite market uncertainties.
- Brenntag SE (BNTGF) is leveraging AI and data analytics for pricing and customer interactions, positioning for long-term growth.
- The company has a defensive business model that benefits from higher price levels and volatility, as seen in the Middle East crisis, supporting gross profit.
- Volumes in the Essentials segment were slightly down year-over-year, with no significant uptick expected in the near term.
- The company experienced a temporary increase in working capital due to higher inventory prices, which could pressure cash flow in the short term.
- Personnel costs rose significantly in Q2, driven by higher bonus provisions, which may not be sustainable if performance normalizes.
- The Nutrition business within Life Science saw flat volumes, with no immediate price pressure from Middle East-related raw materials, limiting growth.
- Management expects gross profit benefits from the Middle East crisis to moderate in Q3 and Q4, potentially reducing over-earnings.
- Chinese competition is returning in Asia and Latin America, particularly in Essentials, which could intensify pricing pressure.
- The company faces ongoing restructuring costs and tax litigation provisions, with no resolution in sight, adding to financial uncertainty.
- Guidance for H2 implies a significant drop in EBITDA from H1 levels, reflecting conservative assumptions about market conditions.
Ladies and gentlemen, thank you for standing by. Welcome to the Brenntag SE Q2 2026 results call and live webcast. Please note that the call will be recorded. (Operator Instructions)
I'd now like to turn the call over to Andre Simon, Senior Vice President, Corporate Investor Relations. Please go ahead.
Thank you, Jenny. Good afternoon, ladies and gentlemen, and a warm welcome to our second quarter [2026] 2d call from my end as well. On the call with me today is our CEO, Jens Birgersson and our CFO, Thomas Reisten.
As you have noticed, we have changed the procedure. We've made available a prerecorded video of the management presentation this morning, together with all the accompanying materials in the Investor Relation section of our web page. With this, we want to give you more time for preparation and the possibility to handle potential overlaps with other earning calls.
Consequently, today's call will focus exclusively on answering your questions. A replay of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
